Funding Cancer Research:
Innovative. Agile. Experienced.

About CR&T

Who We Are

In 1968, Richard T. Silver, MD, a prominent oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer.  While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 50-year history, CR&T has awarded more than $15 million in grants to research that has contributed to major advances in the fight against cancer.

Our Impact

$ -1 M
TO FUND
BLOOD CANCER
RESEARCH
$ -1 M
TO ESTABLISH
THE DR. RICHARD
T. SILVER CHAIR
$ -1 M
TO DOCTORS
FOR OTHER
CANCER RESEARCH

Medical Advisory Board

At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.

Your gift today can help change a cancer patient's life.

Microscope

Looking for other ways you can give?